The centre, which is one of the largest animal hospitals in the UK, offers 14 specialist-led services.
Hospital director Daniel Hogan said: “The new hospital will provide the region with one of the largest and best-equipped veterinary centres in not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
“There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
“The facilities also include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team.
"We also plan to launch our emergency and critical care service in the first half of 2023.”
Southfields says it also aims to lead the industry in terms of staff wellbeing and sustainability.
Daniel said: “The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes such as yoga and boxercise, we will have an education centre which will be able to offer some really exciting qualifications and courses for the wider profession.
“We’ll also be striving to care for both our community by working with Investors in the Environment (iiE) to introduce a bold green initiative to substantially reduce our environmental impact and enhance our sustainability.
https://southfields.co.uk/veterinary-professionals/new-hospital
The buy-out was led by Professor Nick Bacon, Clinical Director, Dr Laurent Findji, Senior Clinician, Dr Jonathan Bray and Dr Gerard McLauchlan, who will collectively take the hospital forward with the financial backing of a small team of external investors.
Professor Noel Fitzpatrick will continue to lead Fitzpatrick Referrals Orthopaedics and Neurology and Fitzpatrick Referrals Institute for the Restoration of Skeletal Tissue which are both based in Eashing, Surrey.
Fitzpatrick Referrals Oncology and Soft Tissue is rebranding as AURA Veterinary, continuing to focus on animal oncology, soft tissue surgery, interventional radiology and internal medicine.
Under the new management team, AURA Veterinary says it has plans to invest in its team, equipment, scientific innovation and research.
Noel said: “I am proud of everything and everyone who has been part of the journey over the last seven years.
"It is a world-class hospital with an unrivalled team and the foundation we have built together is incredible.
"The time is now right for the team to embark on the next part of their journey - allowing me to also go forward and focus my passion, energy and time at Fitzpatrick Referrals Orthopaedics and Neurology and lead that team into its exciting new phase.”
Nick Bacon, Clinical Director, said: “It was a wonderful opportunity to be involved with a hospital like this from the very beginning, and it’s exciting to be part of its new chapter.
"Laurent and I are hugely grateful to Noel for his vision in creating the hospital, which is unparalleled in the level of care, skill and innovation our team can provide for our patients.
"We look forward to the growth and success of AURA Veterinary.”
Photo: Dr Gerard McLauchlan (standing, back left, in darker scrubs), Professor Nick Bacon, Clinical Director (sitting, front left), Dr Jonathan Bray, (sitting, right), Dr Laurent Findji, Senior Clinician (standing, far right)
Q Fever is caused by the bacterium Coxiella burnetii, which can infect humans, cattle, goats, sheep and many other mammals, as well as reptiles, ticks and birds.
Known originally as Query fever, it was first identified in Australia in 1935 after an outbreak of disease in abattoir workers.
Ceva says half of UK dairy farms may be at risk of Q Fever1, 2.
The webinar, which will be presented by Jonathan Statham MA VetMB DCHP FRCVS (pictured right), an RCVS-registered specialist in cattle health and co-author of the ‘Dairy Herd Health’ textbook, will count towards 1.5 hours of CPD.
It will cover the UK prevalence of Q Fever in herds, its cause and transmission, together with identification and diagnostics.
It will also look at the variations between livestock species, disease prevention and its risk to humans as a zoonosis.
Jonathan said: "Q Fever is of much higher profile in many other parts of the world such as Australia and has been notifiable for some years with national testing programmes in a number of European countries such as Germany.
“Recently Q Fever has become notifiable in the UK and climate change is changing the future risk profile."
Renzo Di Florio, veterinary advisor at Ceva said: “The disease causes issues with reproduction and fertility and has the potential to have significant impact on livestock health and productivity.
"However, awareness is low amongst the farming industry.
“Our Q Fever webinar will help raise awareness of the disease and the preventative measures that can be put in place to help protect those working with livestock on a regular basis and reduce the impact of Q Fever on farms.
To register for the webinar or if you have further questions, e-mail cevauk-webinars@ceva.com
References
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.
The BVA is also calling on Government to tighten pet import rules.
The advice follows news about a positive Brucella canis test in a rescue dog imported from Belarus in March this year.
The woman fostering the dog was hospitalised after coming into close contact with it, in the UK’s first confirmed dog-to-human transmission.
The foster animal and four pet dogs who were exposed to the disease, three of whom also tested positive, all had to be euthanised.
Data released by the Government shows a steep rise in confirmed Brucella canis cases since the start of 2020, rising from just three before that year to 107 till July this year.
The dogs were all either imported, had returned from holiday overseas, or been bred with an imported dog.
BVA is asking veterinary teams to:
British Veterinary Association President Justine Shotton said: “This recent case of Brucella canis in a foster dog is extremely tragic and highlights why vets have long raised concerns over the real and serious risks of importing ‘Trojan’ rescue dogs with unknown health histories into the UK.
“We know there is an added public health risk too, including for veterinary teams who treat and handle these animals, from contact with an infected dog’s contaminated body tissues and fluids.
"BVA continues to call on the Government to take urgent action to introduce stricter pet import measures, including mandatory pre-import testing, so we can minimise the spread of Brucella canis and other emerging diseases.
"We are also calling for the strengthening of enforcement provisions and checks on dogs brought into the country through the commercial route."
The 2021 B. canis risk view and statement by Public Health England (now UK Health Security Agency) contains vital information and recommendations for veterinary professionals: here:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960013/20210210_Brucella_canis_statement.pdf
BVA’s recommendations on tightening pet travel legislation: https://www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Policies/Companion_animals/BVA%20Position%20on%20Pet%20Travel%20Full.pdf
Jane (or John) Doe was charged with having stolen midazolam, butorphanol and promethazine hydrochloride from their practice for use other than for veterinary purposes, making false clinical records concerning the use of drugs on their own dogs to disguise the fact that the drugs were instead being used for non-veterinary uses, and drawing up medication taken from the practice into a syringe for the purpose of self-medicating.
In addition, they were charged that their conduct was dishonest.
The Committee found it proven that Jane/John Doe had taken approximately 150 vials of midazolam, 87 ampoules, 112 tablets and one elixir bottle of promethazine hydrocholoride, and 0.2mls of butorphanol together with Iml of midazolam for their dog at a time when their dog was, in fact, dead.
The Committee also found it proven that the defendant had drawn up medication for the purpose of self-medicating, and had created false clinical records.
In deciding the sanction, the Committee concluded that the respondent had abused their position of trust, that their actions were dishonest, prolonged and repeated in nature, and undermined the reputation of the profession as a whole.
Therefore the only appropriate action was removal from the Register.
Unusually, the RCVS did not issue a press release about this case, as it normally does.
There was also a protracted delay between the hearing and the report of the hearing being published on the College website.
Furthermore, when it was finally published, the report had been redacted to remove any reference to the name, gender or location of the respondent.
When asked why, the College said: "Matters of a highly confidential nature arose following the hearing which led to a delay in the decisions being published.
“The decisions have been redacted and we cannot provide the reasons for the redactions as that would necessarily involve disclosure of confidential and personal information.
"However, the circumstances are considered to be exceptional and the College’s decision to make the redactions was only made following very careful consideration of evidence provided to the RCVS.
"The decision has been published on the RCVS website in its redacted form and in view of the timeframe and the circumstances, it has not been considered appropriate to issue a press release.”
CommentThe College will for sure have had very good reasons for redacting the name of the respondent in this case.
One has to assume there must have been a very real threat to the respondent’s life, and under those circumstances, confidentiality is absolutely right and proper.
However, whatever the reason, secrecy is never a good look, especially when it comes in the form of a cape worn by a regulator.
So it is frustrating to hear that the College has again made a rod for its own back, when it could so easily have included a very general one-line explanation for why it felt redaction was necessary, without compromising the individual’s confidentiality.
It would have been enough, for example, just to say that the College felt there was a risk to life. People would accept that.
The technology, developed by US firm SignalPET, sends X-rays through an AI machine algorithm to get a more or less instantaneous report, rather than needing a radiology specialist to analyse results, which can take up to three days.
IVC starting trialling the system with 22 of its practices last November and it quickly became clear that there were huge benefits, including saving time for clinicians, cost, and improving confidence in the diagnosis.
The majority of IVC's trial teams said they viewed the technology as a positive diagnostic aid, supporting their own professional opinion.
It also served as a learning tool, increasing the confidence and clinical independence of younger or newly qualified vets.
Sarah Merrell, Clinical Director at Lincvet, a group of IVC Evidensia practices in Lincoln and one of the trial clinics, said: “SignalPET has proved really valuable – giving us excellent support for radiography.
"It has been used by both our highly experienced and newly graduated clinicians to get a second set of ‘eyes’ on our cases giving reassurance and support when reading our radiographs.
“Overall, it has improved clinician confidence, reduced the pressure on senior vets, given us an additional tool for training and development, and greatly enhanced client understanding of our findings.”
Alistair Cliff, IVC Evidensia’s Deputy Chief Medical Officer, said: “The AI radiology process developed by SignalPET represents a real revolution in how results are analysed.
"The overwhelming success of our initial trial in November means we are confident in pushing ahead with rolling out the technology in the UK this year and eventually, in Europe too."
It's believed that VetSurgeon.org and VetNurse.co.uk, which run on a platform that predates Facebook, may be the first online communities to require good manners.
Under the new policy, anyone who posts anything in the forums which is sarcastic, belittling, snide, rude or unkind towards another member will face immediate removal from the website.
This marks a very radical change to the previous policy in which members were free to say pretty much what they wanted.
VetSurgeon.org Publisher Arlo Guthrie said: "For years, I felt the right to free speech trumped all, and would rarely intervene.
"When I did, the worst anyone faced was a temporary suspension.
"As time has passed, I've realised the limitations of the written word, especially the short-form, hastily-written word, which can cause real distress.
"We all moderate our language offline, it's just a question of realising that we need a different set of standards online, to account for the lack of facial expression and immediacy of reply, and the public nature of the discussion.
Some people have questioned the new policy, and whether it will stifle proper debate.
Arlo added: "I believe not. It is perfectly possible and OK to disagree with someone, and express that disagreement forcefully, without being sarcastic.
"On the contrary, I think that allowing bad manners has a far more chilling effect on free speech, because it scares off opinions from the majority of more moderate members"
Others have asked whether this new policy is the consequence of the new partnership with Improve International, or proposed new laws surrounding social media.
Arlo said: "Again, no. It was a very personal decision I reached after years of wrestling with the problem. It was precipitated by a series of unkind posts and I just thought 'enough's enough'.
"That said, I am really excited about the prospect of working with Improve to grow the community as somewhere its members can come for high quality clinical content and authoritative opinion, which for sure would be hard to achieve if we don't have a friendly, collaborative atmosphere."
Another issue raised about zero tolerance is whether it is fair that there may be no second chance.
Arlo said: "I've tried loads of things over the years. Warnings. Red cards. Suspensions. None of them work. People just push the boundaries.
"But the moment I said 'zero tolerance', it seems people get the message and moderate themselves accordingly."
"I'm delighted. I want people to think of VetSurgeon.org as somewhere everyone can come for authoritative advice and support, confident of a friendly welcome and the highest standards of online behaviour."
In particular, the two companies are focussing on the production of more video content, with Improve filming and sharing high quality clinical demonstrations, and VetSurgeon.org sharing peer-reviewed community-driven content and knowledge.
VetSurgeon.org Publishing Editor Arlo Guthrie said: “This partnership, which brings together the clinical knowledge and infrastructure of the UK’s leading veterinary training provider with the country’s longest-established online veterinary communities, will substantially increase the amount of valuable content we can bring our members.
“Together, we're going to make VetSurgeon.org THE community for authoritative information and opinions."
To ask questions or discuss the new partnership, click here.
Formerly known as BSAVA’s Scottish Congress, Alba delegates will be treated to 28 lectures, four practicals, ten hours of CPD and a commercial exhibition.
There are three lecture streams: one for vets, another for vet nurses and another open to all.
Highlights include ‘Echocardiology’ with Kieran Borgeat, ‘Dermatology: What can nurses do?’ with Sue Paterson, and ‘Wildlife Triage’ with Jenna Richardson.
The practical sessions are open to all and include sampling techniques, suturing and a ferret clinical exam.
There's a gala dinner on Friday 16th from 7:30pm, starting with a drinks reception, followed by dinner and entertainment in the evening, with a live band and ceilidh dancing.
Angela McLaughlin, Scottish Regional Chair at the BSAVA said: “We are delighted that we are returning to Scotland after three years away as this is a great event that allows vets and nurses the opportunity to improve their skills and knowledge, while visiting an idyllic part of the country!”
For BSAVA members, tickets cost £240 +VAT for vets, £165 +VAT for veterinary nurses, and £65 +VAT for students.
Day tickets and non-member tickets are also available.
There's an additional fee of £10 +VAT for all practical sessions.
Tickets for the gala dinner are £35 for delegates and £55 for guests.
If you are looking for somewhere to stay, BSAVA’s hotel booking partner, BCD Meetings & Events, can help.
www.bsavaevents.com/bsavaalba2022
The Canadian company highlights research which showed that the biggest challenge UK veterinary clinics face is the volume of pets (57%), followed by being overbooked (50%) and unable to take on new patients1.
In addition, earlier research has shown that 37%2 of vets are “actively” thinking about quitting, with 80%3 of the UK profession leaving to get a better work-life balance.
Hence the company offers a service through which UK practices can divert non-urgent calls to Vetster, to relieve some of the pressure.
Vetster says the most common cases treated by its veterinary surgeons are dermatology, gastrointestinal, respiratory, urinary tract, ophthalmology and musculoskeletal issues.
By diverting these cases to UK-licensed vets online, Vetster says it aims to relieve the pressure on clinics so that they can better serve pets in need of surgery, immunisations, bloodwork and other clinical treatments.
Mark Bordo, CEO and coFounder of Vetster said: “We are experiencing a global crisis in pet care exacerbated by the pandemic.
“Veterinarians are facing tremendous pressure to provide services to millions of pet owners.
"Vetster’s virtual care platform connects pet owners with licensed UK veterinarians to provide support when their clinic is closed, to answer a non-urgent question, and to improve the health outcomes of their pet and help ensure owners can care for their animals.”
Veterinary surgeons in search of a better work life balance can also join Vetster to create a virtual care practice that provides teletriage and addresses non-urgent issues.
Mark added: “Veterinarians are able to incorporate a new modality of practice to improve their work-life-balance, serve pet owners outside of a clinic environment, and hopefully practice for longer avoiding burnout and stress associated with this much-needed profession.”
Vetster is not available as a white label service at this time, and VetSurgeon.org understands that when it is clear an online consultation requires hands-on care, the owner is referred to the local practice on the platform, which may or may not be their normal practice.
Vets interested in offering consultations through Vetster can visit: https://vetster.com/en-gb/for-vets
Veterinary practices that are interested in having Vetster provide OOH support to clients, can visit: https://vetster.com/en-ca/for-vet-clinics
The study was a randomised controlled trial of client-owned dogs and cats presenting as emergencies and requiring intravenous catheterisation.
Patient signalment and mentation score were recorded.
Patients were randomly allocated to either a swab saturated with vapocoolant spray or a swab saturated with saline applied to the clipped area before intravenous catheterisation.
Indirect application of vapocoolant spray via a swab before catheterisation was not found to significantly reduce the reaction of dogs and cats, nor to improve placement success rates.
The study did demonstrate a significantly greater adverse response to vapocoolant spray application to the skin via a swab when compared with the saline control in canine patients; feline patients demonstrated adverse responses to both vapocoolant spray and saline swabs.
It is unclear if the technique of application used in this study provided sufficient cooling effect to provide the required cryoanaesthesia to influence patient reaction.
The authors say future studies should be used to determine optimal vapocoolant spray application technique in dogs and cats, as well as examine its application in other populations and procedures.
Nicola Di Girolamo, Editor of JSAP concluded: “Pragmatic, adequately-powered, randomised controlled trials like the one presented here are essential to evaluate whether an intervention is not only efficacious in a controlled environment, but also effective during clinical practice.”
Full article: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
Reference
Trinder, R, Humm, K, Phillips, S, and Cole, L (2022) The efficacy of vapocoolant spray for the improved tolerance of catheter pain in emergency patients in dogs Journal of Small Animal Practice, Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
The company says the webinars will equip veterinary professionals with strategies to strengthen wellbeing both individually and for practice teams.
Lauren Hayes, Scientific and Regulatory Affairs Manager at Royal Canin, said: “Working within clinical veterinary practice can be hugely rewarding and enriching, but it cannot be ignored that our industry also has its challenges.
"Veterinary surgeons have a significantly higher risk of suicide compared to the general population and mental health issues around work life balance and compassion fatigue are widespread.
"Through our webinar series, we hope to encourage conversations around mental health and help provide advice directly from leading experts.”
The one-hour webinars will take place at 7pm every Wednesday throughout September.
https://vetportal.royalcanin.co.uk/news/new-veterinary-professional-health-webinar-series/
To help practices make the most of the week, TVM is providing waiting room displays, client leaflets, social media packs and online information to help educate pet owners on the symptoms of poor eye health.
The company will also be holding an webinar for vets and nurses which will be published during the week.
Will Peel, Product Manager at TVM said: "Eye problems in pets are common and brachycephalic breeds are particularly prone to them due to a number of compounding factors.
"They commonly suffer from corneal ulcers and are nearly four times more likely to develop dry eye than other breeds, so Pet Eye Health Awareness Week is focused on helping pet owners understand the issues, identify eye problems early and seek veterinary advice quickly".
www.tvm-uk.com/eyehealth
Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles.
Strangvac contains recombinant proteins CCE, Eq85 and IdeE from Streptococcus equi and has DIVA (Differentiating Infected from Vaccinated Animals) capability.
The vaccine contains no live bacteria or bacterial DNA, so will not trigger positive culture or PCR tests.
In trials the new vaccine protected more than 94% of horses1.
Dechra says it reduces the clinical signs of strangles including a high temperature, coughing, inappetence, difficulty swallowing and changes in demeanour, while also reducing the number of lymph node abscesses.
Strangvac can be given to foals from five months of age and two injections should be given at a four-week interval.
Horses at high risk of Streptococcus equi infection, such as those in livery, should be revaccinated after two months.
Based on measured antibody titres, immunological memory was found in horses following repeated vaccination six months after primary vaccination.
Dr Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the vaccine, said: “Strangvac is a ground-breaking new vaccine which, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry.”
https://www.dechra.co.uk/equine/vaccines
So far this year the charity says it has received 144 requests from people asking for it to take in or help rehome their horse or pony through the Blue Cross Home Direct service.
More than 70% cited personal or financial circumstances as the reason.
In comparison for the full year of 2021, 43 (or around 15%) of a total of 277 intake and rehoming requests specified financial reasons.
In 2020 a total of 32 (around 14%) out of 231 requests stated financial reasons.
Annabelle Taylor, Rehoming Coordinator at Blue Cross, said: “It is distressing to see that the number of people seeking rehoming support because of financial reasons is already more than double last year’s annual total and we still have a third of the year to go.
According to the Spring 2022 Voice of the Profession survey, one in four cats (24%) seen in practices are not having all of their welfare needs met.
The issues identified by vets as the most pressing at their practice were:
With recruitment and retention issues in many sectors of the profession, the Association says flexible working might improve job satisfaction and therefore retention.
Other statistics from the survey showed that whilst levels of flexible working have risen from 44% in 2019 to 50% in 2021, 36% of those who already work flexibly 36% would like more flexibility.
The most common reasons vets gave for wanting to work more flexibly were: to allow more time for leisure activities (56%), lifestyle needs (50%), caregiving responsibilities (28%), health reasons (28%), for professional development (22%) and for voluntary work (16%).
The type of flexibility vets were hoping to achieve also varied. Working part time was the most common type of flexible working sought (31%), followed by homeworking (16%), flexitime (13%) and compressed hours (5%).
As part of its campaign, the BVA has launched "Flexible working: Embracing flexibility in the veterinary profession", a booklet which includes facts, figures and case studies to help demonstrate how flexible working can benefit both employers and employees in a range of different veterinary teams.
The booklet also offers tips and advice on tackling some of the challenges that can arise when introducing increased flexibility into a clinical workplace.
BVA Junior Vice President Malcolm Morley said: “The statistics clearly show that there is a huge appetite for more flexibility in working hours, particularly in clinical practice, where employers have previously been quite hesitant to explore this option.
"We understand that there are potential challenges to allowing more flexibility but we’re hoping to demonstrate that these are not insurmountable.
“It’s vital that the profession recognises that inflexible working patterns contribute to poor retention—recognition is the first stage in finding a solution.
"Embracing developments in flexible working could increase job satisfaction for many team members and ultimately improve retention.”
Malcolm added: “The profession continues to face serious staffing shortages and we understand that the increased pressures on vet teams may make some employers anxious about introducing flexible working at a time when they are already struggling to cover shifts.
"However, the solution does not lie with vet teams working increasingly longer hours; a successful solution will need team members to be involved in supporting each other’s working patterns.
"Promoting a better balance between home and work could be key to supporting many staff who are currently unsure about remaining in the profession or returning to work."
www.bva.co.uk/flexible-working
The app, which works on tablets and smartphones, allows vets to e-mail audit results directly to clients following an interactive calf health assessment at the farm.
MSD Animal Health’s youngstock marketing manager Robert Simpson said: “Our new app allows both parties to explore, record and score calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
“Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention.
"What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets”.
For more information about the app, contact your MSD account manager.
The company says the product improves oral health in three ways: cleaning teeth, freshening breath, and helping to reduce the formation of new plaque and tartar.
The stick is spiral-shaped to maximise contact with the teeth.
As the dog chews, a soft centre is released, which targets the bacteria which causes bad breath and plaque.
Dental Care Sticks are available in three sizes.
Jayne Laycock, Vet in Residence at Yumove said: “Poor dental health affects around 80% of the dog population and is the most commonly reported problem in primary care vet practices.
"We know that less than 50% of dog owners use a dental product as regularly as they should.
"Yumove Dental care sticks can be easily incorporated into a dog’s existing routine and have been developed to clean teeth, tackle bad breath and through our ActivBarrier technology, support the balance of bacteria in a dog’s mouth - helping to maintain healthy gums and teeth.”
YuMOVE Dental Care Sticks start at £10.
www.yumove.co.uk
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
The association says the new Recognised Internships significantly enhance its existing programme which just listed available internships in equine practice.
Over the past year BEVA has worked with veterinary practices across the UK to develop a set of core skills that should be covered during an internship.
These standards sit alongside BEVA's existing Employment Toolkit which outlines what a new graduate should be considering when applying for a job (such as working hours, pay, CPD allowance).
Roger Smith, BEVA Junior Vice President said: “The new programme gives practices constructive guidance to provide a positive and inspirational introduction to a career as an equine vet, rather than the perhaps rushed and unintentionally unstructured, labour focused junior positions that have been experienced in times past.”
BEVA Chief Executive David Mountford said: “We are delighted that nearly 40 equine veterinary practices have already signed up to our Recognised Internships initiative.
"It is such a positive sign that as a profession we are all committed to ensuring we can offer the best start to those entering the profession.”
https://www.beva.org.uk/internships
Practices interested in joining the scheme should contact Fiona Cunnington - fiona@beva.org.uk
Lucy and Rosanna have joined the business in hybrid positions as Novice OVs and will do this alongside working in a clinical practice.
The company says this is a significant milestone for the industry, which has relied on overseas talent for many years.
Eville & Jones says it has now developed a compelling proposition for UK new graduates who want to combine OV work with traditional clinical practice, and vets looking for a lifestyle change or a move away from practice, working flexibly in export certification, abattoir work, certification against standards, or small animal vaccination.
Charles Hartwell, chief executive officer of Eville & Jones said: “The team at Eville & Jones has spent two years developing an attractive proposition to encourage UK-educated veterinary surgeons to consider a career in this field, whether combined with traditional clinical practice, or stand alone.
"We wish Lucy and Rosanna the best of luck and hope they become trailblazers for many others to follow in their footsteps.”
Lucy said: “I’m really excited to be starting my career in veterinary public health where, as an OV, you can positively affect the lives of 1000’s of animals."
Rosanna added: “I’m really proud to have joined the veterinary industry this summer; OVs are instrumental in monitoring and safe-guarding animal welfare in a way that many vets don't realise."
Presented by Louisa Graham PGcertVPS CertAVP(SAM) MRCVS (pictured right), the webinars offer two hours of CPD credits and can be accessed at: https://www.vitaanimalhealth.com/youtube-activation/
Louisa, who has a passion for internal medicine, mentoring and supporting other vets, has built an online following with whom she shares tips and advice.
Vita has also produced two webinars for cat owners which include advice on how to spot signs of OA in cats, when to seek veterinary care and practical tips on how to reduce feline stress.
Vets are encouraged to share these webinars with their clients as a learning tool and source of information.